Disease-associated mutations identify a novel region in human STING necessary for the control of type I interferon signaling
Isabelle Melki(Inserm), Yanick J. Crow(Institute of Genetics and Cancer), Petra De Haes(KU Leuven), Marie‐Anne Morren(KU Leuven), Isabelle Meyts(KU Leuven), Anniek Corveleyn(KU Leuven), Stefano Volpi(Istituto Giannina Gaslini), Naoki Kitabayashi(Délégation Paris 5), Eric Legius(Center for Human Genetics), Marie‐Louise Frémond(Délégation Paris 5), Mathieu P. Rodero(Centre National de la Recherche Scientifique), Christine Bodemer(Hôpital Necker-Enfants Malades), Emma M. Jenkinson(University of Manchester), Marco Gattorno(Istituto Giannina Gaslini), Gillian Rice(Manchester Academic Health Science Centre), Harm A.W.M. Tiddens(Erasmus MC), Oliviero Sacco(Istituto Giannina Gaslini), Isabelle Callebaut(Centre National de la Recherche Scientifique), Frédéric Rieux‐Laucat(Inserm), Carolina Uggenti(Délégation Paris 5), Anaïs Boulai(Délégation Paris 5), Suzanne W. J. Terheggen-Lagro(Emma Kinderziekenhuis), Y Rose(Délégation Paris 5), Carine Wouters(Istituto Giannina Gaslini), Lien Van Eyck(Délégation Paris 5), Nadia Jeremiah(Délégation Paris 5)
Cited by 203
Related Papers
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
Mutations in Fas Associated with Human Lymphoproliferative Syndrome and Autoimmunity
|Science|1995|1.3k